ArticleHealth and quality of life outcomes2026
Translation, cultural adaptation, and psychometric validation of the Chinese versions of the PROMIS + HF-27 and PROMIS + HF-10 profiles in patients with heart failure.
Article in Health and quality of life outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundHeart failure (HF) is a prevalent clinical syndrome characterized by dyspnea, fatigue, exercise intolerance, and oedema, significantly impairing patients’ health-related quality of life (HRQoL). The PROMIS + HF profile is a targeted instrument designed to evaluate novel interventions, enhance clinical care and shared decision-making, and assess quality of care. However, a linguistically validated Chinese version is currently lacking. This study aimed to translate and culturally adapt the PROMIS + HF into Chinese and evaluate its psychometric properties among Chinese patients with HF.
methodsFollowing a standardized cross-cultural adaptation process, the psychometric properties of the Chinese PROMIS + HF profiles (PROMIS + HF-27 and PROMIS + HF-10) were evaluated. A cross-sectional study with a longitudinal component was conducted using convenience sampling to recruit eligible patients from tertiary hospitals in China between September 2022 and February 2023. Participants completed a sociodemographic questionnaire, the PROMIS + HF profiles, the Kansas City Cardiomyopathy Questionnaire (KCCQ), and the Minnesota Living with Heart Failure Questionnaire (MLHFQ). Psychometric evaluation included floor/ceiling effects, construct validity, criterion-related validity, convergent validity, known-groups validity, reliability and responsiveness.
resultsA total of 420 patients (mean age 57.68 years) were included. Both profiles exhibited an absence of floor and ceiling effects. Confirmatory Factor Analysis (CFA) supported the construct validity of both profiles, demonstrating acceptable fit indices after modification (PROMIS + HF-27: χ2/df = 3.874, CFI = 0.869, TLI = 0.855, SRMR = 0.055, RMSEA = 0.08; PROMIS + HF-10: χ2/df = 3.408, CFI = 0.958, TLI = 0.940, SRMR = 0.038, RMSEA = 0.073). Criterion-related validity was supported by significant correlations between overall, physical health scores and the 6-Minute Walk Test (6MWT). Convergent validity was demonstrated through strong correlations with KCCQ and MLHFQ scores, and known-groups validity was confirmed by the instruments’ ability to distinguish between New York Heart Association (NYHA) functional classes. Internal consistency was good to excellent for the PROMIS + HF-27 (Cronbach’s α: 0.87–0.95) and acceptable to good for PROMIS + HF-10 (Cronbach’ α/Spearman-Brown: 0.71–0.88). Test-retest reliability was excellent for both instruments (ICC: 0.89–0.97). Responsiveness was demonstrated in the longitudinal subsample, with medium to large effect sizes (Cohen’s d = 0.41–0.66) observed for most domains, except for the psychological and social scores in the PROMIS + HF-10, which showed small change (Cohen’s d = 0.26–0.29).
conclusionsThe Chinese versions of the PROMIS + HF-27 and PROMIS + HF-10 profiles demonstrate satisfactory psychometric properties, supporting their use for the comprehensive evaluation of HRQoL in Chinese HF patients. The PROMIS + HF-27 is recommended for academic research requiring high precision, whereas the PROMIS + HF-10 offers a time-efficient alternative for routine screening in clinical practice. Future research should further evaluate their predictive validity for long-term prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.